Baugh & Associates, LLC Abbott Laboratories Transaction History

Baugh & Associates, LLC

  • $199 Million
  • Q3 2024

A detailed history of Baugh & Associates, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Baugh & Associates, LLC holds 56,924 shares of ABT stock, worth $6.7 Million. This represents 3.26% of its overall portfolio holdings.

Number of Shares
56,924
Previous 52,187 9.08%
Holding current value
$6.7 Million
Previous $5.42 Million 19.68%
% of portfolio
3.26%
Previous 2.96%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
BUY
$100.07 - $118.13 $474,031 - $559,581
4,737 Added 9.08%
56,924 $6.49 Million
Q2 2024

Jul 12, 2024
SELL
$100.73 - $112.44 $246,486 - $275,140
-2,447 Reduced 4.48%
52,187 $5.42 Million
Q1 2024

Apr 15, 2024
SELL
$109.52 - $120.96 $4,928 - $5,443
-45 Reduced 0.08%
54,634 $6.21 Million
Q4 2023

Jan 10, 2024
SELL
$90.19 - $110.4 $59,705 - $73,084
-662 Reduced 1.2%
54,679 $6.02 Million
Q3 2023

Oct 13, 2023
SELL
$95.53 - $114.62 $6,304 - $7,564
-66 Reduced 0.12%
55,341 $5.36 Million
Q2 2023

Jul 20, 2023
BUY
$100.78 - $112.29 $113,276 - $126,213
1,124 Added 2.07%
55,407 $6.04 Million
Q1 2023

Apr 27, 2023
SELL
$96.86 - $114.01 $125,433 - $147,642
-1,295 Reduced 2.33%
54,283 $5.5 Million
Q4 2022

Jan 27, 2023
BUY
$95.06 - $111.52 $51,047 - $59,886
537 Added 0.98%
55,578 $0
Q3 2022

Oct 07, 2022
SELL
$96.76 - $112.03 $1,451 - $1,680
-15 Reduced 0.03%
55,041 $5.33 Million
Q2 2022

Jul 19, 2022
SELL
$102.07 - $123.37 $5,103 - $6,168
-50 Reduced 0.09%
55,056 $5.98 Million
Q1 2022

Apr 20, 2022
SELL
$114.02 - $139.04 $22,804 - $27,808
-200 Reduced 0.36%
55,106 $6.52 Million
Q4 2021

Jan 14, 2022
SELL
$115.53 - $141.46 $6,585 - $8,063
-57 Reduced 0.1%
55,306 $7.78 Million
Q3 2021

Oct 13, 2021
SELL
$116.66 - $129.06 $2,449 - $2,710
-21 Reduced 0.04%
55,363 $6.54 Million
Q2 2021

Jul 12, 2021
BUY
$105.79 - $124.53 $315,465 - $371,348
2,982 Added 5.69%
55,384 $6.42 Million
Q1 2021

Apr 16, 2021
SELL
$108.84 - $128.23 $10,666 - $12,566
-98 Reduced 0.19%
52,402 $6.28 Million
Q4 2020

Jan 13, 2021
SELL
$105.0 - $114.42 $83,685 - $91,192
-797 Reduced 1.5%
52,500 $5.75 Million
Q3 2020

Oct 28, 2020
SELL
$91.64 - $111.29 $66,072 - $80,240
-721 Reduced 1.33%
53,297 $5.8 Million
Q2 2020

Jul 09, 2020
SELL
$76.57 - $98.0 $3,598 - $4,606
-47 Reduced 0.09%
54,018 $4.94 Million
Q1 2020

Apr 21, 2020
SELL
$62.82 - $91.86 $272,701 - $398,764
-4,341 Reduced 7.43%
54,065 $4.27 Million
Q4 2019

Jan 13, 2020
SELL
$78.51 - $87.4 $45,614 - $50,779
-581 Reduced 0.98%
58,406 $5.07 Million
Q3 2019

Oct 08, 2019
SELL
$81.84 - $88.74 $30,690 - $33,277
-375 Reduced 0.63%
58,987 $4.94 Million
Q2 2019

Jul 23, 2019
SELL
$72.88 - $85.0 $24,414 - $28,475
-335 Reduced 0.56%
59,362 $4.99 Million
Q1 2019

Apr 05, 2019
SELL
$66.22 - $80.06 $22,183 - $26,820
-335 Reduced 0.56%
59,697 $4.77 Million
Q4 2018

Jan 17, 2019
SELL
$65.56 - $74.27 $28,649 - $32,455
-437 Reduced 0.72%
60,032 $4.34 Million
Q3 2018

Nov 02, 2018
SELL
$60.81 - $73.36 $6,993 - $8,436
-115 Reduced 0.19%
60,469 $4.44 Million
Q2 2018

Jul 27, 2018
SELL
$57.57 - $63.54 $289,864 - $319,923
-5,035 Reduced 7.67%
60,584 $3.7 Million
Q1 2018

Apr 25, 2018
BUY
$56.27 - $63.62 $98,753 - $111,653
1,755 Added 2.75%
65,619 $3.93 Million
Q4 2017

Feb 08, 2018
BUY
$53.68 - $57.47 $3.43 Million - $3.67 Million
63,864
63,864 $3.65 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Baugh & Associates, LLC Portfolio

Follow Baugh & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baugh & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baugh & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email